Skip to main content
ABX
NYSE Finance

Abacus Q2 Revenue Jumps 32% but Costs Surge, Squeezing Profits

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Negative
Importance info
8
Price
$9.52
Mkt Cap
$913.181M
52W Low
$5
52W High
$12.44
52W Position info
90% above low
Off High info
23% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ABX sits 90% above its 52-week low of $5.

Summary

Abacus Global Management delivered a 32% revenue increase to $132.4M for H1 2026, yet net income fell 37% to $13.9M as operating expenses surged 76%, led by a near-doubling of G&A costs. Cash reserves declined while debt remains high, though a new $75M credit line offers some relief.


Key Events · Earnings and Guidance · ABX

  • Revenue Growth Overshadowed by Cost Surge

    Total revenue rose 32% YoY to $132.4M for H1 2026, but net income attributable to Abacus fell 37% to $13.9M as operating expenses jumped 76% to $77.2M.

  • G&A Expenses Nearly Double

    General and administrative expenses surged 89% to $58.8M, driven by a $14.2M increase in legal and professional fees, raising concerns about cost control.

  • Valuation Methodology Change

    The company adopted a Historical Return Method for valuing life settlement policies, replacing the prior discounted cash flow model, which could alter the pattern of reported gains.

  • Liquidity Tightens

    Cash and equivalents fell to $23.4M from $38.1M at year-end, while total debt stands at $330.6M. A $75M credit facility amendment was signed but not yet funded as of June 30.


Analysis · ABX · Finance

A 32% revenue surge to $132.4M in the first half of 2026, powered by the Life Solutions segment, was undercut by a 76% jump in operating expenses that drove net income attributable to the company down 37% to $13.9M. General and administrative costs nearly doubled, reflecting a $14.2M spike in legal and professional fees. A shift in valuation methodology for life settlement policies could reshape the pattern of future reported gains. Meanwhile, cash reserves have dwindled to $23.4M against $330.6M in total debt, though a $75M credit facility amendment—signed but not yet funded—offers a potential liquidity bridge. The picture is one of robust top-line momentum overshadowed by escalating overhead and a tightening balance sheet.

At the time of this filing, ABX was trading at $9.52 on NYSE in the Finance sector, with a market capitalization of approximately $913.2M. The 52-week trading range was $5.00 to $12.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ABX - Latest Insights

ABX
Aug 04, 2026, 10:50 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.79
Real-time Price: $9.80 info
Change: -$0.990 (-9%) info
Market Cap: $913.181M info
ABX
Jul 02, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.85
Real-time Price: $9.80 info
Change: -$2.05 (-17%) info
Market Cap: $913.181M info
ABX
Jun 10, 2026, 8:59 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $9.01
Real-time Price: $9.80 info
Change: +$0.790 (+9%) info
Market Cap: $913.181M info
ABX
Jun 04, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.87
Real-time Price: $9.80 info
Change: +$0.930 (+10%) info
Market Cap: $913.181M info
ABX
May 27, 2026, 11:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.47
Real-time Price: $9.80 info
Change: +$0.330 (+3%) info
Market Cap: $913.181M info